Generic Name: delavirdine
Other Market Name: N/A
Company: ViiV Healthcare
Approval Status: Approved
Generic Version Available: No
Experimental Code: N/A
Not part of a recommended or alternative treatment regimen for antiretroviral-naive people living with HIV, according to the U.S. Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents. Visit http://aidsinfo.nih.gov/contentfiles/lvguidelines/aa_recommendations.pdf for the full DHHS guidelines.
Rescriptor is an HIV medication. It is in a category of HIV medicines called non-nucleoside reverse transcriptase inhibitors. Rescriptor was approved by the U.S. Food and Drug Administration for use by people living with HIV in 1997.
Rescriptor must be used in combination with other HIV drugs.
Adult Dose: Two 200mg tablets three times a day or four 100mg tablets three times a day.
Pediatric Dose: N/A
Dosing Info: Take with or without food.
The most common side effect of Rescriptor is mild-to-moderate skin rash. In a small number of patients, rash has been serious and resulted in death. Therefore, if you develop a rash with any of the following symptoms, call your doctor immediately: general ill feeling, fever, muscle or joint aches, blisters, mouth sores, conjunctivitis (inflammation of the inner surface of the eyelids), swelling of the face, tiredness.
Other possible side effects include nausea, diarrhea, headache, and fatigue.
For a review of drug interactions, including prescription and over-the-counter medications and supplements that should not be taken with Rescriptor or may require dose adjustments, consult the Rescriptor package insert: https://www.viivhealthcare.com/media/32314/us_rescriptor.pdf
Before taking this medication, tell your doctor if you have kidney disease or liver disease (including hepatitis B). In addition, tell your doctor if you are pregnant or planning to become pregnant, if you are breastfeeding, and all your medical conditions, including all prescription and over-the-counter medications and supplements you are taking.
For More Info: https://www.viivhealthcare.com/media/32314/us_rescriptor.pdf
Co-Pay Program Info: https://www.poz.com/basics/hiv-basics/drug-assistance-programs
Patient Assistance Program Info: https://www.poz.com/basics/hiv-basics/drug-assistance-programs
Last Revised: July 15, 2016